




Instance: composition-en-06d503464480447969e787c60d8f32dd
InstanceOf: CompositionUvEpi
Title: "Composition for supemtek Package Leaflet"
Description:  "Composition for supemtek Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp740ee9bcdb86bf190ac88526dfc87f9c)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - supemtek"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol>
<li>What Supemtek is and what it is used for  </li>
<li>What you need to know before you receive  Supemtek </li>
<li>How Supemtek is given </li>
<li>Possible side effects </li>
<li>How to store Supemtek </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What supemtek is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What supemtek is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Supemtek is a vaccine for adults who are 18 years of age and older. This vaccine helps to protect 
you against flu (influenza). Supemtek is egg-free because of the technology used to produce it. </p>
<p>How Supemtek works 
When a person is given Supemtek, the body s natural defence (the immune system) produces 
protection against the influenza virus. None of the ingredients in the vaccine can cause flu. 
As with all vaccines, Supemtek may not fully protect all persons who are vaccinated. </p>
<p>When to have a flu vaccine 
Flu can spread very fast.<br />
<em> It is caused by different types of flu virus that can change every year. This is why you might 
need to be vaccinated every year.<br />
</em> The greatest risk of catching flu is during the cold months between October and March.<br />
* If you were not vaccinated in the autumn, it is still sensible to be vaccinated up until the spring 
since you run the risk of catching flu until then.<br />
Your doctor will be able to recommend the best time to be vaccinated. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take supemtek"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take supemtek"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use Supemtek if you are allergic to :<br />
<em> the active ingredients or any of the other ingredients of this medicine (listed in section 6).<br />
</em> octylphenol ethoxylate, a trace residual from the manufacturing process.  </p>
<p>Warnings and precautions<br />
Talk to your doctor, pharmacist or nurse before receiving Supemtek. 
As with all vaccines, Supemtek may not fully protect all persons who are vaccinated. 
Before receiving the vaccine, tell your doctor, nurse or pharmacist if: 
* you have a short-term illness with fever. Vaccination may need to be delayed until your 
fever has gone. 
* you have a weakened immune system (immunodeficiency or you are taking medicines that 
affect the immune system such as cancer medicine (chemotherapy) or corticosteroid 
medicines). 
* you have a bleeding problem or bruise easily. 
* you have fainted with an injection before. Fainting can happen after, or even before an 
injection. 
If any of the above apply to you (or you are not sure) talk to your doctor, pharmacist or nurse before 
receiving Supemtek.  </p>
<p>Other medicines and Supemtek 
Tell your doctor or nurse if you are using, have recently used or might use any other medicines, 
including medicines obtained without a prescription or if you have recently received any other 
vaccine.<br />
Supemtek may be given at the same time as other vaccines by using separate limbs. </p>
<p>Pregnancy and breast-feeding<br />
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before using this vaccine. Your doctor or pharmacist will help 
you to decide if you should receive Supemtek. </p>
<p>Driving and using machines 
Supemtek has no or negligible effect on your ability to drive and use machine. </p>
<p>Supemtek contains sodium <br />
This vaccine contains less than 1 mmol sodium (23 mg) per dose, this means that it s essentially 
 sodium free .  </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take supemtek"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take supemtek"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Supemtek is given to you by your doctor, nurse or pharmacist as an injection into the muscle at the 
top of the upper arm (deltoid muscle). 
Adults from 18 years of age and older: 
One dose of 0.5 mL. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Severe allergic reactions 
Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency 
room right away if you have an allergic reaction. It can be life-threatening. 
Symptoms include: 
* difficulty breathing, shortness of breath<br />
<em> swelling of the face, lips, throat or tongue<br />
</em> cold, clammy skin<br />
* palpitations 
* feeling dizzy, feeling weak, fainting 
* rash or itching </p>
<p>The following side effects have been reported with Supemtek: </p>
<p>Other side effects 
Very common (may affect more than 1 in 10 people): 
* pain at the injection site 
* feeling tired (fatigue)<br />
<em> headache<br />
</em> muscle pain and joint pain<br />
Muscle pain and joint pain are common in adults aged 50 years and older. </p>
<p>Common (may affect up to 1 in 10 people):<br />
* feeling sick (nausea) 
* redness, swelling, hardening around the area where the vaccine is injected 
* fever, shivering<br />
Fever is rare in adults aged 50 years and older. </p>
<p>Uncommon (may affect up to 1 in 100 people): 
* diarrhoea 
* itching, skin irritation, rash 
* flu-like symptoms 
* cough, mouth and throat pain 
* itching where the vaccine is injected 
Itching is rare in adults aged 50 years and older. 
Skin irritation and rash have not been reported in adults aged 50 years and older. 
Flu-like symptoms has not been reported in adults aged 18-49 years. </p>
<p>Rare (may affect up to 1 in 1000 people): 
* feeling dizzy 
* hives<br />
Feeling dizzy and hives have not been reported in adults aged 18-49 years. </p>
<p>Not known (cannot be estimated from the available data): 
* neurological disorders that may result in stiff neck, confusion, numbness, pain and weakness of 
the limbs, loss of balance, loss of reflexes, paralysis of part or all the body (Guillain-Barr<br />
syndrome). </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on 
the safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store supemtek"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store supemtek"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this vaccine out of the sight and reach of children. </p>
<p>Store in a refrigerator (2 C - 8 C). Do not freeze. 
Keep the pre-filled syringe in the outer carton in order to protect from light. </p>
<p>Do not use this vaccine after the expiry date which is stated on the label and carton after EXP. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask you pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Supemtek contains 
One dose (0.5 mL) contains: 
The active substances are influenza virus haemagglutinin (HA) proteins, of the following strains*: 
A/xxxxxx (H1N1) -like virus ......................................... 45 micrograms HA 
A/xxxxxx (H3N2) -like virus ......................................... 45 micrograms HA 
B/xxxxxx- like virus....................................................... 45 micrograms HA 
B/xxxxxx - like virus...................................................... 45 micrograms HA </p>
<ul>
<li>produced by recombinant DNA technology using a baculovirus expression system in a continuous 
insect cell line that is derived from Sf9 cells of the fall armyworm, Spodoptera frugiperda. </li>
</ul>
<p>This vaccine complies with the World Health Organisation (WHO) recommendation (northern 
hemisphere) and EU recommendation for the {year/year} season.<br />
The other ingredients are: polysorbate 20 (E432), sodium chloride, sodium phosphate monobasic, 
sodium phosphate dibasic, water for injections. </p>
<p>What Supemtek looks like and contents of the pack 
Supemtek is a solution for injection in a pre-filled syringe (ready to use syringe).<br />
Supemtek is a clear and colourless solution. 
A single syringe contains 0.5 mL of solution for injection.  </p>
<p>Supemtek is available in packs containing 1, 5 or 10 pre-filled syringes without needle or with 
separate needle. 
Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder 
Sanofi Pasteur 
14 Espace Henry Vall e 
69007 Lyon 
France </p>
<p>Manufacturer 
Sanofi Pasteur 
Parc Industriel d'Incarville 
27100 Val de Reuil 
France </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi / Belgique /Belgien 
Sanofi Belgium 
T l/Tel.: +32 2 710.54.Lietuva 
Swixx Biopharma UAB 
Tel: +370 5 236 91 <br />
Swixx Biopharma EOOD 
 .: +359 (0) 2 4942 Luxembourg/Luxemburg 
Sanofi Belgium 
tel.: +32 2 710.54. esk  republika 
Sanofi s.r.o. 
Tel: +420 233 086 Magyarorsz g 
sanofi-aventis zrt 
Tel.: +36 1 505 0Danmark 
Sanofi A/S 
Tel: +45 4516 7Malta 
Sanofi S.r.l. 
Tel: +39 02 39394Deutschland 
Sanofi-Aventis Deutschland GmbH 
Tel.: 0800 54 54 Tel. aus dem Ausland: +49 69 305 21 Nederland 
Sanofi B.V. 
Tel: +31 20 245 4Eesti 
Swixx Biopharma O <br />
Tel: +372 640 10 Norge 
Sanofi-aventis Norge AS 
Tel: + 47 67 10 71 <br />
   . .<br />
 : +30.210.8009 sterreich 
Sanofi-Aventis GmbH 
Tel: +43 (1) 80185-0. Espa a 
sanofi-aventis, S.A.<br />
Tel: +34 93 485 94 Polska 
Sanofi Pasteur Sp. z o. o. 
Tel.: +48 22 280 00 France 
Sanofi Pasteur Europe 
T l: 0800 222 Appel depuis l tranger : +33 1 57 63 23 Portugal 
Sanofi   Produtos Farmac uticos, Lda. 
Tel: + 351 21 35 89 Hrvatska 
Swixx Biopharma d.o.o. 
Tel: +385 1 2078 Rom nia 
Sanofi Romania SRL 
Tel.: +40(21) 317 31 Ireland 
sanofi-aventis Ireland T/A SANOFI 
Tel: + 353 (0) 1 4035 Slovenija 
Swixx Biopharma d.o.o.<br />
Tel: +386 1 235 51  sland 
Vistor 
Tel : +354 535 7Slovensk  republika 
Swixx Biopharma s.r.o. 
Tel: +421 2 208 33 Italia 
Sanofi S.r.l. 
Tel: 800536Suomi/Finland 
Sanofi Oy 
Tel: +358 (0) 201 200 <br />
C.A. Papaellinas Ltd. 
 : +357 22 741Sverige 
Sanofi AB 
Tel: +46 8-634 50 Latvija<br />
Swixx Biopharma SIA<br />
Tel: +371 6 616 47 United Kingdom (Northern Ireland) 
sanofi-aventis Ireland Ltd. T/A SANOFI 
Tel: +44 (0) 800 035 2This leaflet was last revised in {XX/YYYY}.<br />
Other sources of information 
Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-06d503464480447969e787c60d8f32dd
InstanceOf: CompositionUvEpi
Title: "Composition for supemtek Package Leaflet"
Description:  "Composition for supemtek Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp740ee9bcdb86bf190ac88526dfc87f9c)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - supemtek"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse<br />
2. Det skal du vide, før du får Supemtek 
3. Sådan får du Supemtek 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What supemtek is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What supemtek is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Supemtek er en vaccine til voksne på 18 år og derover. Vaccinen hjælper med at beskytte dig mod 
influenza. På grund af den teknologi, der er anvendt til fremstillingen, indeholder Supemtek ikke æg. </p>
<p>Sådan virker Supemtek 
Når man bliver vaccineret med Supemtek, danner kroppens naturlige forsvarsmekanisme 
(immunsystemet) beskyttelse mod influenzavirus. Ingen af ingredienserne i vaccinen kan fremkalde 
influenza. 
I lighed med alle andre vacciner, er det muligt, at Supemtek ikke fuldstændigt beskytter alle de 
personer, som bliver vaccineret. </p>
<p>Hvornår bør du få en influenzavaccine? 
Influenza kan sprede sig meget hurtigt.  </p>
<ul>
<li>
<p>Den forårsages af forskellige typer influenzavirus, der kan ændre sig fra år til år. Derfor skal du 
muligvis vaccineres hvert år.  </p>
</li>
<li>
<p>Den største risiko for at få influenza er i de kolde måneder mellem oktober og marts.  </p>
</li>
<li>
<p>Hvis du ikke er blevet vaccineret i efteråret, er det stadig klogt at lade sig vaccinere frem til 
foråret, da du løber en risiko for at få influenza indtil da. 
Lægen kan fortælle dig, hvornår det er bedst at lade sig vaccinere.  </p>
</li>
</ul>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take supemtek"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take supemtek"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brug ikke Supemtek, hvis du er allergisk over for:</p>
<ul>
<li>de aktive stoffer eller et af de øvrige indholdsstoffer i dette lægemiddel (angivet i afsnit 6). </li>
<li>octylphenolethoxylat, et reststof i meget små mængder fra fremstillingsprocessen.  </li>
</ul>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen, apotekspersonalet eller sygeplejersken, før du får Supemtek. </p>
<p>I lighed med alle andre vacciner, er det muligt, at Supemtek ikke fuldstændigt beskytter alle de 
personer, som bliver vaccineret. </p>
<p>Før du får vaccinen, skal du fortælle det til lægen, sygeplejersken eller apotekspersonalet, hvis: </p>
<ul>
<li>
<p>du har en kortvarig sygdom med feber. Det vil måske være nødvendigt at udskyde 
vaccinationen indtil feberen er forsvundet. </p>
</li>
<li>
<p>du har nedsat immunforsvar (immundefekt eller du bruger lægemidler, der påvirker 
immunsystemet som f.eks. cancermedicin (kemoterapi) eller lægemidler indeholdende 
kortikosteroider). </p>
</li>
<li>
<p>du har blødningsproblemer eller nemt får blå mærker. </p>
</li>
<li>
<p>du før er besvimet i forbindelse med en indsprøjtning. Man kan besvime efter eller endda 
inden, man får en indsprøjtning. 
Fortæl det til lægen, apotekspersonalet eller sygeplejersken, før du får Supemtek, hvis et eller flere af 
ovenstående punkter gælder for dig (eller hvis du er i tvivl).  </p>
</li>
</ul>
<p>Brug af anden medicin sammen med Supemtek 
Fortæl det altid til lægen eller sygeplejersken, hvis du bruger anden medicin, for nylig har brugt anden 
medicin eller planlægger at bruge anden medicin. Dette gælder også medicin, som ikke er købt på 
recept, eller hvis du for nyligt har fået en anden vaccination. 
Supemtek kan gives samtidigt med andre vacciner, men i forskellige lemmer. </p>
<p>Graviditet og amning<br />
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge eller apotekspersonalet til råds, før du bruger denne vaccine. 
Lægen eller apotekspersonalet vil hjælpe dig med at afgøre, om du skal have Supemtek. </p>
<p>Trafik- og arbejdssikkerhed 
Supemtek påvirker ikke eller kun i ubetydelig grad din evne til at føre motorkøretøj og arbejde med 
maskiner. </p>
<p>Supemtek indeholder natrium 
Denne vaccine indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, dvs. det er i den væsentlige 
natriumfri. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take supemtek"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take supemtek"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Din læge, sygeplejersken eller apotekspersonalet vil give dig Supemtek som en injektion i musklen 
øverst på overarmen (deltoidmusklen). </p>
<p>Voksne på 18 år og derover: 
En dosis på 0,5 ml. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Alvorlige allergiske reaktioner 
Kontakt straks din læge eller sundhedspersonalet, eller tag straks til nærmeste skadestue, hvis du får 
en allergisk reaktion. Det kan være livsfarligt. 
Symptomerne kan være: </p>
<ul>
<li>
<p>vejrtrækningsbesvær, åndenød  </p>
</li>
<li>
<p>hævelse af ansigt, læber, svælg eller tunge  </p>
</li>
<li>
<p>kold, klam hud  </p>
</li>
<li>
<p>hjertebanken </p>
</li>
<li>
<p>svimmelhed, svaghedsfølelse, besvimelse </p>
</li>
<li>
<p>udslæt eller kløe </p>
</li>
</ul>
<p>Følgende bivirkninger er rapporteret med Supemtek: </p>
<p>Andre bivirkninger 
Meget almindelig (kan forekomme hos flere end 1 ud af 10 personer): </p>
<ul>
<li>
<p>smerter på injektionsstedet </p>
</li>
<li>
<p>træthed (udmattelse)  </p>
</li>
<li>
<p>hovedpine  </p>
</li>
<li>
<p>muskel- og ledsmerter<br />
Muskel- og ledsmerter er almindelige hos voksne i alder 50 år og derover. </p>
</li>
</ul>
<p>Almindelig (kan forekomme hos op til 1 ud af 10 personer):  </p>
<ul>
<li>
<p>kvalme </p>
</li>
<li>
<p>rødme, hævelse, hårdhed ved injektionsstedet </p>
</li>
<li>
<p>feber, kulderystelser<br />
Feber er sjælden hos voksne i alderen 50 år og derover. </p>
</li>
</ul>
<p>Ikke almindelig (kan forekomme hos op til 1 ud af 100 personer): </p>
<ul>
<li>
<p>diarré </p>
</li>
<li>
<p>kløe, hudirritation, udslæt </p>
</li>
<li>
<p>influenzalignende symptomer </p>
</li>
<li>
<p>hoste, smerter i mund og svælg </p>
</li>
<li>
<p>kløe ved injektionsstedet 
Kløe er sjælden hos voksne i alderen 50 år og derover. 
Hudirritation og udslæt er ikke blevet rapporteret hos voksne i alderen 50 år og derover. 
Influenzalignende symptomer er ikke blevet rapporteret hos voksne i alderen 18-49 år. </p>
</li>
</ul>
<p>Sjælden (kan forekomme hos op til 1 ud af 1.000 personer): </p>
<ul>
<li>
<p>svimmelhed </p>
</li>
<li>
<p>nældefeber<br />
Svimmelhed og nældefeber er ikke blevet rapporteret hos voksne i alderen 18-49 år. </p>
</li>
</ul>
<p>Ikke kendt (kan ikke estimeres ud fra forhåndenværende data): </p>
<ul>
<li>neurologiske forstyrrelser som kan medføre nakkestivhed, forvirring, følelsesløshed, smerter og 
svaghed i arme og ben, tab af balance, tab af reflekser, lammelse i dele eller hele kroppen 
(Guillain-Barré syndrom). </li>
</ul>
<p>Indberetning af bivirkninger<br />
Hvis du oplever bivirkninger, bør du tale med din læge, apotekspersonalet eller sygeplejersken. Dette 
gælder også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende 
kan også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V. Ved at indrapportere bivirkninger du hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store supemtek"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store supemtek"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar vaccinen utilgængeligt for børn. </p>
<p>Opbevares i køleskab (2°C - 8°C).<br />
Må ikke nedfryses.<br />
Opbevar den fyldte injektionssprøjte i den ydre æske for at beskytte mod lys. </p>
<p>Brug ikke vaccinen efter den udløbsdato, der står på etiketten og æsken efter EXP.  </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Supemtek indeholder: </p>
<p>En dosis (0,5 ml) indeholder: 
Aktive stoffer: Influenzavirus hæmagglutinin (HA) proteiner fra følgende stammer*: 
A/XXXXXX (H1N1)-lignende virus .......... 45 mikrogram HA 
A/XXXXXX (H3N2)-lignende virus .......... 45 mikrogram HA 
B/XXXXXX-lignende virus ........................ 45 mikrogram HA 
B/XXXXXX-lignende virus ........................ 45 mikrogram HA </p>
<p>*produceret ved hjælp af rekombinant DNA-teknologi med brug af et Baculovirus-system i en 
kontinuerlig insekt cellelinje, som stammer fra Sf9-celler fra Spodoptera frugiperda larven. </p>
<p>Denne vaccine følger WHO’s anbefalinger (nordlige halvkugle) og EU’s beslutning for sæson 
XXXX/XXXX. </p>
<p>Øvrige indholdsstoffer: polysorbat 20 (E432), natriumchlorid, natriumdihydrogenphosphat, 
dinatriumphosphat, vand til injektionsvæsker. </p>
<p>Udseende og pakningsstørrelser 
Supemtek er en injektionsvæske, opløsning i en fyldt injektionssprøjte (klar til brug-injektionssprøjte).<br />
Supemtek er en klar og farveløs opløsning. 
En enkelt injektionssprøjte indeholder 0,5 ml injektionsvæske, opløsning.  </p>
<p>Supemtek fås i pakninger med 1, 5 eller 10 fyldte injektionssprøjter uden kanyle eller med separat 
kanyle. 
Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen<br />
Sanofi Pasteur 
14 Espace Henry Vallée 
69007 Lyon 
Frankrig </p>
<p>Fremstiller 
Sanofi Pasteur 
Parc Industriel d'Incarville 
27100 Val de Reuil 
Frankrig </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/ Belgique /Belgien 
Sanofi Belgium 
Tél/Tel.: +32 02 710.54.Lietuva 
Swixx Biopharma UAB 
Tel: +370 5 236 91 България 
Swixx Biopharma EOOD 
Тел.: +359 (0) 2 4942 Luxembourg/Luxemburg 
Sanofi Belgium 
tel.: +32 2 710.54.Česká republika 
Sanofi s.r.o. 
Tel: +420 233 086 Magyarország 
sanofi-aventis zrt 
Tel.: +36 1 505 0Danmark 
Sanofi A/S 
Tel: +45 4516 7Malta 
Sanofi S.r.l. 
Tel: +39 02 39394Deutschland 
Sanofi-Aventis Deutschland GmbH 
Tel.: 0800 54 54 Tel. aus dem Ausland: +49 69 305 21 Nederland 
Sanofi B.V. 
Tel: +31 20 245 4Eesti 
Swixx Biopharma OÜ 
Tel: +372 640 10 Norge 
Sanofi-aventis Norge AS 
Tel: + 47 67 10 71 Ελλάδα 
ΒΙΑΝΕΞ Α.Ε.<br />
Τηλ: +30.210.8009Österreich 
Sanofi-Aventis GmbH 
Tel: +43 (1) 80185-0. España 
sanofi-aventis, S.A.<br />
Tel: +34 93 485 94 Polska 
Sanofi Pasteur Sp. z o. o. 
Tel.: +48 22 280 00 France 
Sanofi Pasteur Europe 
Tél: 0800 222 Appel depuis l’étranger : +33 1 57 63 23 Portugal 
Sanofi - Produtos Farmacêuticos, Lda. 
Tel: + 351 21 35 89 Hrvatska 
Swixx Biopharma d.o.o. 
Tel: +385 1 2078 România 
Sanofi Romania SRL 
Tel.: +40(21) 317 31 Ireland 
sanofi-aventis Ireland T/A SANOFI 
Tel: + 353 (0) 1 4035 Slovenija 
Swixx Biopharma d.o.o. 
Tel: +386 1 235 51 Ísland 
Vistor 
Tel : +354 535 7Slovenská republika 
Swixx Biopharma s.r.o. 
Tel: +421 2 208 33 Italia 
Sanofi S.r.l. 
Tel: 800536Suomi/Finland 
Sanofi Oy 
Tel: +358 (0) 201 200 Κύπρος 
C.A. Papaellinas Ltd.
Τηλ: +357 22 741741
Sverige 
Sanofi AB 
Tel: +46 8-634 50 Latvija 
Swixx Biopharma SIA 
Tel: +371 6 616 47 United Kingdom (Northern Ireland) 
sanofi-aventis Ireland Ltd. T/A SANOFI 
Tel: +44 (0) 800 035 2Denne indlægsseddel blev senest ændret {MM/ÅÅÅÅ} 
Andre informationskilder 
Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu<br />
------------------------------------------------------------------------------------------------------------------------ Nedenstående oplysninger er til læger og sundhedspersonale: </p>
<p>Relevant medicinsk behandling og overvågning skal altid være let tilgængelig i tilfælde af, at der 
opstår en sjælden anafylaktisk reaktion efter administration af vaccinen. </p>
<p>Vaccinen skal inspiceres visuelt for partikler og misfarvning før administration. Hvis der observeres 
fremmede partikler og/eller afvigende fysisk udseende, må vaccinen ikke administreres. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-06d503464480447969e787c60d8f32dd
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for supemtek Package Leaflet for language en"
Description: "ePI document Bundle for supemtek Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-06d503464480447969e787c60d8f32dd"
* entry[0].resource = composition-en-06d503464480447969e787c60d8f32dd

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp06d503464480447969e787c60d8f32dd"
* entry[=].resource = mp06d503464480447969e787c60d8f32dd
                            
                    
Instance: bundlepackageleaflet-da-06d503464480447969e787c60d8f32dd
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for supemtek Package Leaflet for language da"
Description: "ePI document Bundle for supemtek Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-06d503464480447969e787c60d8f32dd"
* entry[0].resource = composition-da-06d503464480447969e787c60d8f32dd

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp06d503464480447969e787c60d8f32dd"
* entry[=].resource = mp06d503464480447969e787c60d8f32dd
                            
                    



Instance: mp06d503464480447969e787c60d8f32dd
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Supemtek solution for injection in pre-filled syringe"
Description: "Supemtek solution for injection in pre-filled syringe"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/20/1484/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Supemtek solution for injection in pre-filled syringe"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 06d503464480447969e787c60d8f32ddListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "supemtek"

* status = #current
* mode = #working

* title = "List of all ePIs associated with supemtek"

* subject = Reference(mp740ee9bcdb86bf190ac88526dfc87f9c)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#supemtek "supemtek"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-06d503464480447969e787c60d8f32dd) // supemtek en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-06d503464480447969e787c60d8f32dd) // supemtek da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-06d503464480447969e787c60d8f32dd
InstanceOf: List

* insert 06d503464480447969e787c60d8f32ddListRuleset
    